Megakaryocyte-mediated inhibition of osteoclast development

被引:72
作者
Kacena, Melissa A.
Nelson, Tracy
Clough, Mary E.
Lee, Sun-Kyeong
Lorenzo, Joseph A.
Gundberg, Caren M.
Horowitz, Mark C.
机构
[1] Yale Univ, Sch Med, Dept Orthopaed & Rehabil, New Haven, CT 06520 USA
[2] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT 06030 USA
关键词
megakaryocyte; osteoclast inhibition; OPG; cytokine;
D O I
10.1016/j.bone.2006.05.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A growing body of evidence indicates that megakaryocytes (MK) or their growth factors play a role in skeletal homeostasis. We previously identified a novel regulatory pathway that controls bone formation, which is mediated by MK. In vivo megakaryocytosis resulted in massive bone formation. The co-culture of MK with osteoblasts (OB) resulted in increased OB proliferation in vitro, by a mechanism that required direct cell-to-cell contact. Here, we examined a second MK-mediated pathway that regulates osteoclast (OC) development. We have begun examining the unique inhibitory effect of MK on OC development. Spleen or bone marrow (BM) cells from C57BL/6 mice, as a source of OC precursors, were cultured with M-CSF and RANKL to induce OC development. MK were prepared by culturing fetal liver cells with thrombopoietin and separating cells into MK and non-MK populations. MK were titrated into spleen cell cultures and OC were identified as tartrate-resistant acid phosphatase-positive giant cells with > 3 nuclei. There was a significant, P < 0.001, up to 10-fold reduction in OC formed when MK were added to the spleen cell cultures. We determined that 30% (vol:vol) MK conditioned media (CM) were able to completely block OC development from precursors, whereas 3% MK CM resulted in up to a 10-fold reduction in OC development, P < 0.001. These data indicate that a soluble factor(s) was responsible, at least in part, for the inhibition. We examined MK CM for known inhibitors of OC formation, using ELISAs. IL-4,,vas undetectable in MK CM, whereas IL-10 and IFN-gamma levels were similar in MK and non-MK CM. TGF beta-1 levels were increased 2-fold in MK CM compared to control CM but were not responsible for the inhibition in OC development. Although, we found a significant increase in the levels of osteoprotegerin (OPG) in MK CM, antibody neutralization studies, MK derived from OPG-deficient mice, and tandem mass spectrophotometry, all confirm that OPG was not responsible for the MK-mediated inhibition of OC development. Overall, these data suggest that ail unidentified factor(s) is present in MK CM that inhibits OC development. These studies indicate that MK can play a dual role in skeletal homeostasis by stimulating OB proliferation and simultaneously inhibiting OC development. (C) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:991 / 999
页数:9
相关论文
共 55 条
[1]   IDENTIFICATION AND CLONING OF A MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR THAT IS A LIGAND FOR THE CYTOKINE RECEPTOR MPL [J].
BARTLEY, TD ;
BOGENBERGER, J ;
HUNT, P ;
LI, YS ;
LU, HS ;
MARTIN, F ;
CHANG, MS ;
SAMAL, B ;
NICHOL, JL ;
SWIFT, S ;
JOHNSON, MJ ;
HSU, RY ;
PARKER, VP ;
SUGGS, S ;
SKRINE, JD ;
MEREWETHER, LA ;
CLOGSTON, C ;
HSU, E ;
HOKOM, MM ;
HORNKOHL, A ;
CHOI, E ;
PANGELINAN, M ;
SUN, Y ;
MAR, V ;
MCNINCH, J ;
SIMONET, L ;
JACOBSEN, F ;
XIE, C ;
SHUTTER, J ;
CHUTE, H ;
BASU, R ;
SELANDER, L ;
TROLLINGER, D ;
SIEU, L ;
PADILLA, D ;
TRAIL, G ;
ELLIOTT, G ;
IZUMI, R ;
COVEY, T ;
CROUSE, J ;
GARCIA, A ;
XU, W ;
DELCASTILLO, J ;
BIRON, J ;
COLE, S ;
HU, MCT ;
PACIFICI, R ;
PONTING, I ;
SARIS, C ;
WEN, D .
CELL, 1994, 77 (07) :1117-1124
[2]   Synthesis of osteoprotegerin and RANKL by megakaryocytes is modulated by oestrogen [J].
Bord, S ;
Frith, E ;
Ireland, DC ;
Scott, MA ;
Craig, JIO ;
Compston, JE .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 126 (02) :244-251
[3]   Megakaryocytes modulate osteoblast synthesis of type-1 collagen, osteoprotegerin, and RANKL [J].
Bord, S ;
Frith, E ;
Ireland, DC ;
Scott, MA ;
Craig, JIO ;
Compston, JE .
BONE, 2005, 36 (05) :812-819
[4]   osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification [J].
Bucay, N ;
Sarosi, I ;
Dunstan, CR ;
Morony, S ;
Tarpley, J ;
Capparelli, C ;
Scully, S ;
Tan, HL ;
Xu, WL ;
Lacey, DL ;
Boyle, WJ ;
Simonet, WS .
GENES & DEVELOPMENT, 1998, 12 (09) :1260-1268
[5]   Expression of osteoprotegerin mRNA and protein in murine megakaryocytes [J].
Chagraoui, H ;
Sabri, S ;
Capron, C ;
Villeval, JL ;
Vainchenker, W ;
Wendling, F .
EXPERIMENTAL HEMATOLOGY, 2003, 31 (11) :1081-1088
[6]   TRANSFORMING GROWTH FACTOR-BETA INHIBITS FORMATION OF OSTEOCLAST-LIKE CELLS IN LONG-TERM HUMAN MARROW CULTURES [J].
CHENU, C ;
PFEILSCHIFTER, J ;
MUNDY, GR ;
ROODMAN, GD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (15) :5683-5687
[7]   Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development [J].
Cornish, J ;
Callon, KE ;
Bava, U ;
Kamona, SA ;
Cooper, GJS ;
Reid, IR .
BONE, 2001, 29 (02) :162-168
[8]  
DEMPSTER DW, 1987, J BONE MINER RES, V2, P443
[9]   STIMULATION OF MEGAKARYOCYTOPOIESIS AND THROMBOPOIESIS BY THE C-MPL LIGAND [J].
DESAUVAGE, FJ ;
HASS, PE ;
SPENCER, SD ;
MALLOY, BE ;
GURNEY, AL ;
SPENCER, SA ;
DARBONNE, WC ;
HENZEL, WJ ;
WONG, SC ;
KUANG, WJ ;
OLES, KJ ;
HULTGREN, B ;
SOLBERG, LA ;
GOEDDEL, DV ;
EATON, DL .
NATURE, 1994, 369 (6481) :533-538
[10]   Thrombopoietin signal transduction in purified murine megakaryocytes [J].
Drachman, JG ;
Sabath, DF ;
Fox, NE ;
Kaushansky, K .
BLOOD, 1997, 89 (02) :483-492